169 related articles for article (PubMed ID: 26869337)
1. Fibroblast Growth Factor-10 (FGF-10) Mobilizes Lung-resident Mesenchymal Stem Cells and Protects Against Acute Lung Injury.
Tong L; Zhou J; Rong L; Seeley EJ; Pan J; Zhu X; Liu J; Wang Q; Tang X; Qu J; Bai C; Song Y
Sci Rep; 2016 Feb; 6():21642. PubMed ID: 26869337
[TBL] [Abstract][Full Text] [Related]
2. Mesenchymal stem cells ameliorate LPS-induced acute lung injury through KGF promoting alveolar fluid clearance of alveolar type II cells.
Li JW; Wu X
Eur Rev Med Pharmacol Sci; 2015 Jul; 19(13):2368-78. PubMed ID: 26214771
[TBL] [Abstract][Full Text] [Related]
3. Evidence for tissue-resident mesenchymal stem cells in human adult lung from studies of transplanted allografts.
Lama VN; Smith L; Badri L; Flint A; Andrei AC; Murray S; Wang Z; Liao H; Toews GB; Krebsbach PH; Peters-Golden M; Pinsky DJ; Martinez FJ; Thannickal VJ
J Clin Invest; 2007 Apr; 117(4):989-96. PubMed ID: 17347686
[TBL] [Abstract][Full Text] [Related]
4. Human Mesenchymal Stem (Stromal) Cells Promote the Resolution of Acute Lung Injury in Part through Lipoxin A4.
Fang X; Abbott J; Cheng L; Colby JK; Lee JW; Levy BD; Matthay MA
J Immunol; 2015 Aug; 195(3):875-81. PubMed ID: 26116507
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic potential of porcine bronchoalveolar fluid-derived mesenchymal stromal cells in a pig model of LPS-induced ALI.
Khatri M; Richardson LA
J Cell Physiol; 2018 Jul; 233(7):5447-5457. PubMed ID: 29231967
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic effect of intravenous bone marrow-derived mesenchymal stem cell transplantation on early-stage LPS-induced acute lung injury in mice.
Tai WL; Dong ZX; Zhang DD; Wang DH
Nan Fang Yi Ke Da Xue Xue Bao; 2012 Mar; 32(3):283-90. PubMed ID: 22445968
[TBL] [Abstract][Full Text] [Related]
7. Orbital Fibroblasts From Graves' Orbitopathy Patients Share Functional and Immunophenotypic Properties With Mesenchymal Stem/Stromal Cells.
Brandau S; Bruderek K; Hestermann K; Görtz GE; Horstmann M; Mattheis S; Lang S; Eckstein A; Berchner-Pfannschmidt U
Invest Ophthalmol Vis Sci; 2015 Oct; 56(11):6549-57. PubMed ID: 26457540
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic Effects of Bone Marrow-Derived Mesenchymal Stem Cells in Models of Pulmonary and Extrapulmonary Acute Lung Injury.
Liu L; He H; Liu A; Xu J; Han J; Chen Q; Hu S; Xu X; Huang Y; Guo F; Yang Y; Qiu H
Cell Transplant; 2015; 24(12):2629-42. PubMed ID: 25695285
[TBL] [Abstract][Full Text] [Related]
9. Mesenchymal stem cell-based developmental endothelial locus-1 gene therapy for acute lung injury induced by lipopolysaccharide in mice.
Zhao YF; Xiong W; Wu XL
Mol Med Rep; 2014 May; 9(5):1583-9. PubMed ID: 24573341
[TBL] [Abstract][Full Text] [Related]
10. Bone marrow-derived mesenchymal stem cells attenuate phosgene-induced acute lung injury in rats.
Chen J; Shao Y; Xu G; Lim C; Li J; Xu D; Shen J
Inhal Toxicol; 2015; 27(5):254-61. PubMed ID: 25970824
[TBL] [Abstract][Full Text] [Related]
11. Intratracheal transplantation of human umbilical cord blood-derived mesenchymal stem cells dose-dependently attenuates hyperoxia-induced lung injury in neonatal rats.
Chang YS; Choi SJ; Sung DK; Kim SY; Oh W; Yang YS; Park WS
Cell Transplant; 2011; 20(11-12):1843-54. PubMed ID: 23167961
[TBL] [Abstract][Full Text] [Related]
12. The hepatocyte growth factor-expressing character is required for mesenchymal stem cells to protect the lung injured by lipopolysaccharide in vivo.
Hu S; Li J; Xu X; Liu A; He H; Xu J; Chen Q; Liu S; Liu L; Qiu H; Yang Y
Stem Cell Res Ther; 2016 Apr; 7(1):66. PubMed ID: 27129877
[TBL] [Abstract][Full Text] [Related]
13. BM cells giving rise to MSC in culture have a heterogeneous CD34 and CD45 phenotype.
Kaiser S; Hackanson B; Follo M; Mehlhorn A; Geiger K; Ihorst G; Kapp U
Cytotherapy; 2007; 9(5):439-50. PubMed ID: 17786605
[TBL] [Abstract][Full Text] [Related]
14. Mesenchymal stem cells reduce cigarette smoke-induced inflammation and airflow obstruction in rats via TGF-β1 signaling.
Song L; Guan XJ; Chen X; Cui ZL; Han FF; Guo XJ; Xu WG
COPD; 2014 Sep; 11(5):582-90. PubMed ID: 24766333
[TBL] [Abstract][Full Text] [Related]
15. Markers distinguishing mesenchymal stem cells from fibroblasts are downregulated with passaging.
Halfon S; Abramov N; Grinblat B; Ginis I
Stem Cells Dev; 2011 Jan; 20(1):53-66. PubMed ID: 20528146
[TBL] [Abstract][Full Text] [Related]
16. Mesenchymal stromal cell injection protects against oxidative stress in Escherichia coli-induced acute lung injury in mice.
Shalaby SM; El-Shal AS; Abd-Allah SH; Selim AO; Selim SA; Gouda ZA; Abd El Motteleb DM; Zanfaly HE; El-Assar HM; Abdelazim S
Cytotherapy; 2014 Jun; 16(6):764-75. PubMed ID: 24525173
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic effects of bone marrow-derived mesenchymal stem cells on pulmonary impact injury complicated with endotoxemia in rats.
Zhao Y; Yang C; Wang H; Li H; Du J; Gu W; Jiang J
Int Immunopharmacol; 2013 Feb; 15(2):246-53. PubMed ID: 23273653
[TBL] [Abstract][Full Text] [Related]
18. Suspension-Expansion of Bone Marrow Results in Small Mesenchymal Stem Cells Exhibiting Increased Transpulmonary Passage Following Intravenous Administration.
Zanetti A; Grata M; Etling EB; Panday R; Villanueva FS; Toma C
Tissue Eng Part C Methods; 2015 Jul; 21(7):683-92. PubMed ID: 25567723
[TBL] [Abstract][Full Text] [Related]
19. Mesenchymal Stem Cells Overexpressing Angiotensin-Converting Enzyme 2 Rescue Lipopolysaccharide-Induced Lung Injury.
He H; Liu L; Chen Q; Liu A; Cai S; Yang Y; Lu X; Qiu H
Cell Transplant; 2015; 24(9):1699-715. PubMed ID: 25291359
[TBL] [Abstract][Full Text] [Related]
20. Intravenous transplantation of mesenchymal stem cells attenuates oleic acid induced acute lung injury in rats.
Xu YL; Liu YL; Wang Q; Li G; Lü XD; Kong B
Chin Med J (Engl); 2012 Jun; 125(11):2012-8. PubMed ID: 22884070
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
